Protocol Details
Prospective Study of Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
This study is currently recruiting participants.
Summary
Number |
20-C-0161 |
Sponsoring Institute |
National Cancer Institute (NCI) |
Recruitment Detail |
Type: Participants currently recruited/enrolled
Gender: Male & Female
Min Age: 6 Years
Max Age: N/A |
Referral Letter Required |
No |
Population Exclusion(s) |
None |
Keywords |
Tyrosine Kinase Inhibitor (TKI) Therapy;
Wild-Type GISTs (WT GISTs);
PDGFRA Mutation;
KIT Mutation;
SDH Mutation;
Natural History |
Recruitment Keyword(s) |
None |
Condition(s) |
Gastric Cancer;
Gastric Neoplasm;
Gastrointestinal Stromal Sarcoma;
Gastrointestinal Stromal Neoplasm;
Gastrointestinal Stromal Tumor (GIST) |
Investigational Drug(s) |
None |
Investigational Device(s) |
None |
Intervention(s) |
None |
Supporting Site |
National Cancer Institute |
Objective:
To follow people with GISTs and collect tumor tissue so that it can be studied in the lab.
Eligibility:
People age 6 and older who have a GIST.
Design:
Participants will be screened with a review of their medical records and samples.
Participants will enroll in 1 other NIH study, and may be asked to enroll in 2 other optional NIH studies.
Participants will have a medical history and physical exam. Data about how they function in their daily activities will be obtained.
Participants may speak with a genetic counselor. They may have genetic testing.
Participants will give blood samples. They may have a cheek swab. For this, small brush will be rubbed against the inside of the cheek.
Participants may have a computed tomography (CT) scan of the chest, abdomen, and pelvis. Or they may have a CT scan of the chest and magnetic resonance imaging (MRI) of the abdomen and pelvis.
Participants will be monitored every 6-12 months at the NIH Clinical Center, for up to 10 years before having surgery. If they need surgery, it will be performed at the NIH. Then, they will be monitored every 6-12 months, for up to 5 years after surgery.
If a participant has surgery, tumor tissue samples and research specimen will be taken.
If a participant does not need surgery, their participation will end after 10 years. If they have surgery, the 5-year monitoring period will restart after each surgery.
Eligibility
INCLUSION CRITERIA:
- Histological confirmation or clinical presentation suspicious of GIST; histological confirmation will be preferably by review of archival tissue if available, fresh biopsy will not be required if inadequate tissue sample.
- Age >= 6 years
- ECOG performance status <= 2 (Karnofsky or Lansky >= 60%)
- Ability of participant or parent/guardian to understand and the willingness to sign a written informed consent document.
EXCLUSION CRITERIA:
- Non-modifiable medical comorbidities that would preclude cytoreductive surgery.
Citations:
Not Provided
Contacts:
Clinical Trials Number:
NCT04557969